share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

SEC announcement ·  Mar 7 06:16
Summary by Futu AI
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of company stock on March 4, 2024. The transaction involved the disposal of 4,782 shares of common stock at a price of $11.1212 per share. Following the sale, Burnett's direct holdings in the company amount to 269,300 shares. The total value of the shares sold is approximately $53,181.58. This sale was executed in the open market and is part of the normal course of investment transactions.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of company stock on March 4, 2024. The transaction involved the disposal of 4,782 shares of common stock at a price of $11.1212 per share. Following the sale, Burnett's direct holdings in the company amount to 269,300 shares. The total value of the shares sold is approximately $53,181.58. This sale was executed in the open market and is part of the normal course of investment transactions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.